535 related articles for article (PubMed ID: 17179478)
1. Dietary fat reduction and breast cancer outcome: interim efficacy results from the Women's Intervention Nutrition Study.
Chlebowski RT; Blackburn GL; Thomson CA; Nixon DW; Shapiro A; Hoy MK; Goodman MT; Giuliano AE; Karanja N; McAndrew P; Hudis C; Butler J; Merkel D; Kristal A; Caan B; Michaelson R; Vinciguerra V; Del Prete S; Winkler M; Hall R; Simon M; Winters BL; Elashoff RM
J Natl Cancer Inst; 2006 Dec; 98(24):1767-76. PubMed ID: 17179478
[TBL] [Abstract][Full Text] [Related]
2. Adherence to a dietary fat intake reduction program in postmenopausal women receiving therapy for early breast cancer. The Women's Intervention Nutrition Study.
Chlebowski RT; Blackburn GL; Buzzard IM; Rose DP; Martino S; Khandekar JD; York RM; Jeffery RW; Elashoff RM; Wynder EL
J Clin Oncol; 1993 Nov; 11(11):2072-80. PubMed ID: 8229121
[TBL] [Abstract][Full Text] [Related]
3. Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial.
Prentice RL; Caan B; Chlebowski RT; Patterson R; Kuller LH; Ockene JK; Margolis KL; Limacher MC; Manson JE; Parker LM; Paskett E; Phillips L; Robbins J; Rossouw JE; Sarto GE; Shikany JM; Stefanick ML; Thomson CA; Van Horn L; Vitolins MZ; Wactawski-Wende J; Wallace RB; Wassertheil-Smoller S; Whitlock E; Yano K; Adams-Campbell L; Anderson GL; Assaf AR; Beresford SA; Black HR; Brunner RL; Brzyski RG; Ford L; Gass M; Hays J; Heber D; Heiss G; Hendrix SL; Hsia J; Hubbell FA; Jackson RD; Johnson KC; Kotchen JM; LaCroix AZ; Lane DS; Langer RD; Lasser NL; Henderson MM
JAMA; 2006 Feb; 295(6):629-42. PubMed ID: 16467232
[TBL] [Abstract][Full Text] [Related]
4. Dietary patterns in women treated for breast cancer who successfully reduce fat intake: the Women's Intervention Nutrition Study (WINS).
Winters BL; Mitchell DC; Smiciklas-Wright H; Grosvenor MB; Liu W; Blackburn GL
J Am Diet Assoc; 2004 Apr; 104(4):551-9. PubMed ID: 15054339
[TBL] [Abstract][Full Text] [Related]
5. Influence of a diet very high in vegetables, fruit, and fiber and low in fat on prognosis following treatment for breast cancer: the Women's Healthy Eating and Living (WHEL) randomized trial.
Pierce JP; Natarajan L; Caan BJ; Parker BA; Greenberg ER; Flatt SW; Rock CL; Kealey S; Al-Delaimy WK; Bardwell WA; Carlson RW; Emond JA; Faerber S; Gold EB; Hajek RA; Hollenbach K; Jones LA; Karanja N; Madlensky L; Marshall J; Newman VA; Ritenbaugh C; Thomson CA; Wasserman L; Stefanick ML
JAMA; 2007 Jul; 298(3):289-98. PubMed ID: 17635889
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal changes in body weight and body composition among women previously treated for breast cancer consuming a high-vegetable, fruit and fiber, low-fat diet.
Thomson CA; Rock CL; Giuliano AR; Newton TR; Cui H; Reid PM; Green TL; Alberts DS;
Eur J Nutr; 2005 Feb; 44(1):18-25. PubMed ID: 15309460
[TBL] [Abstract][Full Text] [Related]
7. [Breast-conserving treatment for early invasive lobular breast cancer: 15 years results].
Fodor J; Sulyok Z; Polgár C; Major T; Tóth J; Németh G
Magy Seb; 2001 Aug; 54(4):209-14. PubMed ID: 11550486
[TBL] [Abstract][Full Text] [Related]
8. Dietary Modification and Breast Cancer Mortality: Long-Term Follow-Up of the Women's Health Initiative Randomized Trial.
Chlebowski RT; Aragaki AK; Anderson GL; Pan K; Neuhouser ML; Manson JE; Thomson CA; Mossavar-Rahmani Y; Lane DS; Johnson KC; Wactawski-Wende J; Snetselaar L; Rohan TE; Luo J; Barac A; Prentice RL;
J Clin Oncol; 2020 May; 38(13):1419-1428. PubMed ID: 32031879
[TBL] [Abstract][Full Text] [Related]
9. Multicentric and multifocal versus unifocal breast cancer: is the tumor-node-metastasis classification justified?
Weissenbacher TM; Zschage M; Janni W; Jeschke U; Dimpfl T; Mayr D; Rack B; Schindlbeck C; Friese K; Dian D
Breast Cancer Res Treat; 2010 Jul; 122(1):27-34. PubMed ID: 20454925
[TBL] [Abstract][Full Text] [Related]
10. Reduction in fat intake is not associated with weight loss in most women after breast cancer diagnosis: evidence from a randomized controlled trial.
Rock CL; Thomson C; Caan BJ; Flatt SW; Newman V; Ritenbaugh C; Marshall JR; Hollenbach KA; Stefanick ML; Pierce JP
Cancer; 2001 Jan; 91(1):25-34. PubMed ID: 11148556
[TBL] [Abstract][Full Text] [Related]
11. Implementing a low-fat eating plan in the Women's Intervention Nutrition Study.
Hoy MK; Winters BL; Chlebowski RT; Papoutsakis C; Shapiro A; Lubin MP; Thomson CA; Grosvenor MB; Copeland T; Falk E; Day K; Blackburn GL
J Am Diet Assoc; 2009 Apr; 109(4):688-96. PubMed ID: 19328264
[TBL] [Abstract][Full Text] [Related]
12. Randomized phase 3 trial of fluorouracil, epirubicin, and cyclophosphamide alone or followed by Paclitaxel for early breast cancer.
Martín M; Rodríguez-Lescure A; Ruiz A; Alba E; Calvo L; Ruiz-Borrego M; Munárriz B; Rodríguez CA; Crespo C; de Alava E; López García-Asenjo JA; Guitián MD; Almenar S; González-Palacios JF; Vera F; Palacios J; Ramos M; Gracia Marco JM; Lluch A; Alvarez I; Seguí MA; Mayordomo JI; Antón A; Baena JM; Plazaola A; Modolell A; Pelegrí A; Mel JR; Aranda E; Adrover E; Alvarez JV; García Puche JL; Sánchez-Rovira P; Gonzalez S; López-Vega JM;
J Natl Cancer Inst; 2008 Jun; 100(11):805-14. PubMed ID: 18505968
[TBL] [Abstract][Full Text] [Related]
13. Combination of everolimus with trastuzumab plus paclitaxel as first-line treatment for patients with HER2-positive advanced breast cancer (BOLERO-1): a phase 3, randomised, double-blind, multicentre trial.
Hurvitz SA; Andre F; Jiang Z; Shao Z; Mano MS; Neciosup SP; Tseng LM; Zhang Q; Shen K; Liu D; Dreosti LM; Burris HA; Toi M; Buyse ME; Cabaribere D; Lindsay MA; Rao S; Pacaud LB; Taran T; Slamon D
Lancet Oncol; 2015 Jul; 16(7):816-29. PubMed ID: 26092818
[TBL] [Abstract][Full Text] [Related]
14. The impact of lobular and ductal breast cancer histology on the metastatic behavior and long term survival of breast cancer patients.
Korhonen T; Kuukasjärvi T; Huhtala H; Alarmo EL; Holli K; Kallioniemi A; Pylkkänen L
Breast; 2013 Dec; 22(6):1119-24. PubMed ID: 23863867
[TBL] [Abstract][Full Text] [Related]
15. Dramatic dietary fat reduction is feasible for breast cancer patients: Results of the randomised study, WINS (UK) - stage 1.
Parry BM; Milne JM; Yadegarfar G; Rainsbury RM
Eur J Surg Oncol; 2011 Oct; 37(10):848-55. PubMed ID: 21868187
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant zoledronic acid in patients with early breast cancer: final efficacy analysis of the AZURE (BIG 01/04) randomised open-label phase 3 trial.
Coleman R; Cameron D; Dodwell D; Bell R; Wilson C; Rathbone E; Keane M; Gil M; Burkinshaw R; Grieve R; Barrett-Lee P; Ritchie D; Liversedge V; Hinsley S; Marshall H;
Lancet Oncol; 2014 Aug; 15(9):997-1006. PubMed ID: 25035292
[TBL] [Abstract][Full Text] [Related]
17. A randomized trial of dietary intervention for breast cancer prevention.
Martin LJ; Li Q; Melnichouk O; Greenberg C; Minkin S; Hislop G; Boyd NF
Cancer Res; 2011 Jan; 71(1):123-33. PubMed ID: 21199800
[TBL] [Abstract][Full Text] [Related]
18. Low-fat dietary pattern and cancer incidence in the Women's Health Initiative Dietary Modification Randomized Controlled Trial.
Prentice RL; Thomson CA; Caan B; Hubbell FA; Anderson GL; Beresford SA; Pettinger M; Lane DS; Lessin L; Yasmeen S; Singh B; Khandekar J; Shikany JM; Satterfield S; Chlebowski RT
J Natl Cancer Inst; 2007 Oct; 99(20):1534-43. PubMed ID: 17925539
[TBL] [Abstract][Full Text] [Related]
19. Re: Dietary fat reduction and breast cancer outcome: interim efficacy results from the Women's Intervention Nutrition Study.
Pierce JP; Natarajan L; Marshall J; Messer K
J Natl Cancer Inst; 2007 Jun; 99(11):900; author reply 900-1. PubMed ID: 17551155
[No Abstract] [Full Text] [Related]
20. Re: Dietary fat reduction and breast cancer outcome: interim efficacy results from the Women's Intervention Nutrition Study.
Kurt M; Altundag K
J Natl Cancer Inst; 2007 Jun; 99(11):899-900; author reply 900-1. PubMed ID: 17551152
[No Abstract] [Full Text] [Related]
[Next] [New Search]
